These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 29784849

  • 1. Evaluation of Telavancin Alone and Combined with Ceftaroline or Rifampin against Methicillin-Resistant Staphylococcus aureus in an In Vitro Biofilm Model.
    Jahanbakhsh S, Singh NB, Yim J, Rose WE, Rybak MJ.
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784849
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
    Barber KE, Smith JR, Ireland CE, Boles BR, Rose WE, Rybak MJ.
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4497-503. PubMed ID: 25987623
    [Abstract] [Full Text] [Related]

  • 3. Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms.
    Kunz Coyne AJ, Stamper K, Bleick C, Kebriaei R, Lehman SM, Rybak MJ.
    Microbiol Spectr; 2024 Apr 02; 12(4):e0321223. PubMed ID: 38411110
    [Abstract] [Full Text] [Related]

  • 4. Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an In Vitro Biofilm Model.
    Jahanbakhsh S, Singh NB, Yim J, Kebriaei R, Smith JR, Lev K, Tran TT, Rose WE, Arias CA, Rybak MJ.
    Antimicrob Agents Chemother; 2020 Apr 21; 64(5):. PubMed ID: 32094136
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.
    El Haj C, Murillo O, Ribera A, Lloberas N, Gómez-Junyent J, Tubau F, Fontova P, Cabellos C, Ariza J.
    Int J Antimicrob Agents; 2018 Jun 21; 51(6):854-861. PubMed ID: 29374577
    [Abstract] [Full Text] [Related]

  • 6. Activity of Telavancin against Staphylococcus aureus Isolates, Including Those with Decreased Susceptibility to Ceftaroline, from Cystic Fibrosis Patients.
    Roch M, Varela MC, Taglialegna A, Rose WE, Rosato AE.
    Antimicrob Agents Chemother; 2018 Sep 21; 62(9):. PubMed ID: 29914961
    [Abstract] [Full Text] [Related]

  • 7. Activity of telavancin against Staphylococcus aureus strains with various vancomycin susceptibilities in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
    Leonard SN, Vidaillac C, Rybak MJ.
    Antimicrob Agents Chemother; 2009 Jul 21; 53(7):2928-33. PubMed ID: 19414568
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Telavancin in therapy of experimental aortic valve endocarditis in rabbits due to daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus.
    Xiong YQ, Hady WA, Bayer AS, Chen L, Kreiswirth BN, Yang SJ.
    Antimicrob Agents Chemother; 2012 Nov 21; 56(11):5528-33. PubMed ID: 22890759
    [Abstract] [Full Text] [Related]

  • 11. Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.
    Parra-Ruiz J, Vidaillac C, Rose WE, Rybak MJ.
    Antimicrob Agents Chemother; 2010 Oct 21; 54(10):4329-34. PubMed ID: 20696880
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative activities of telavancin combined with nafcillin, imipenem, and gentamicin against Staphylococcus aureus.
    Leonard SN, Supple ME, Gandhi RG, Patel MD.
    Antimicrob Agents Chemother; 2013 Jun 21; 57(6):2678-83. PubMed ID: 23545527
    [Abstract] [Full Text] [Related]

  • 14. Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis.
    LaPlante KL, Woodmansee S.
    Antimicrob Agents Chemother; 2009 Sep 21; 53(9):3880-6. PubMed ID: 19564363
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In Vitro Pharmacodynamics of Human Simulated Exposures of Telavancin against Methicillin-Susceptible and -Resistant Staphylococcus aureus with and without Prior Vancomycin Exposure.
    Thabit AK, Nicolau DP, Kuti JL.
    Antimicrob Agents Chemother; 2016 Jan 21; 60(1):222-8. PubMed ID: 26482306
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of Oritavancin Combinations with Rifampin, Gentamicin, or Linezolid against Prosthetic Joint Infection-Associated Methicillin-Resistant Staphylococcus aureus Biofilms by Time-Kill Assays.
    Yan Q, Karau MJ, Raval YS, Patel R.
    Antimicrob Agents Chemother; 2018 Oct 21; 62(10):. PubMed ID: 30012765
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy of dalbavancin alone and with rifampicin against in vitro biofilms in a pharmacodynamic model with methicillin-resistant Staphylococcus aureus.
    El Haj C, Benavent E, Sierra Y, Soldevila L, Rigo-Bonnin R, Torrejón B, Gomez-Junyent J, Rosselló I, Murillo O.
    Int J Antimicrob Agents; 2022 Oct 21; 60(4):106664. PubMed ID: 36002115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.